| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/06/2023 | Reneo Pharmaceuticals, Inc. | RPHM | Grant | Stock Option (right to buy) | 17.5k | $9.01 | $157.7k | | 06/06/2023 |
| 01/24/2023 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 6.4k | $21.50 | $138.5k | | 01/24/2023 |
| 01/05/2023 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 5.6k | $20.75 | $116.7k | | 01/05/2023 |
| 06/01/2022 | Reneo Pharmaceuticals, Inc. | RPHM | Grant | Stock Option (right to buy) | 17.5k | $2.09 | $36.6k | | 06/01/2022 |
| 02/10/2022 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 4.8k | $27.84 | $134.5k | | 02/10/2022 |
| 01/31/2022 | Travere Therapeutics, Inc. | RTRX | Grant | Performance-based restricted stock units | 37.8k | $0.00 | $0 | | 01/31/2022 |
| 01/31/2022 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 37.8k | $0.00 | $0 | | 01/31/2022 |
| 01/31/2022 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 4.8k | $27.40 | $131.9k | | 01/31/2022 |
| 01/31/2022 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 169.6k | $27.50 | $4.7M | | 01/31/2022 |
| 01/24/2022 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 7.9k | $24.98 | $196.7k | | 01/24/2022 |
| 01/05/2022 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 2.1k | $30.48 | $65.2k | | 01/04/2022 |
| 01/05/2022 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 10.4k | $29.84 | $309.2k | | 01/04/2022 |
| 01/04/2022 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 4.8k | $30.43 | $147k | | 01/04/2022 |
| 06/02/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 4.8k | $14.35 | $68.6k | | 06/01/2021 |
| 06/01/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 4.8k | $14.89 | $71.2k | | 06/01/2021 |
| 02/08/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 4.8k | $31.58 | $152k | | 02/05/2021 |
| 02/05/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 4.8k | $31.41 | $151.2k | | 02/05/2021 |
| 02/03/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 2.4k | $28.91 | $69.6k | | 02/03/2021 |
| 02/03/2021 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 17.5k | $0.00 | $0 | | 02/03/2021 |
| 02/02/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 6.3k | $29.60 | $187.3k | | 01/31/2021 |
| 02/02/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 2.4k | $30.75 | $74k | | 01/31/2021 |
| 01/31/2021 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 15k | $0.00 | $0 | | 01/31/2021 |
| 01/21/2021 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 212.7k | $26.88 | $5.7M | | 01/21/2021 |
| 01/21/2021 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 212.6k | $26.88 | $5.7M | | 01/21/2021 |
| 01/21/2021 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 57.3k | $0.00 | $0 | | 01/21/2021 |
| 01/06/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 3.4k | $27.01 | $92.9k | | 01/05/2021 |
| 01/05/2021 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 3.4k | $26.65 | $91.6k | | 01/05/2021 |
| 09/21/2020 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 9.2k | $19.28 | $178.1k | | 09/18/2020 |
| 09/21/2020 | Travere Therapeutics, Inc. | RTRX | Sale | Common Stock | 1.6k | $19.29 | $30.2k | | 09/18/2020 |
| 09/18/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 3k | $0.00 | $0 | | 09/18/2020 |
| 09/18/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 25k | $0.00 | $0 | | 09/18/2020 |
| 01/31/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 35k | $0.00 | $0 | | 01/31/2020 |
| 01/31/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 300k | $15.46 | $4.6M | | 01/31/2020 |
| 01/31/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Performance-based restricted stock units | 35k | $0.00 | $0 | | 01/31/2020 |
| 01/31/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Performance-based restricted stock units | 30k | $0.00 | $0 | | 01/31/2020 |
|